PUBLISHER: The Business Research Company | PRODUCT CODE: 1948210
PUBLISHER: The Business Research Company | PRODUCT CODE: 1948210
Sleep apnea devices encompass a range of advanced equipment, notably Continuous Positive Airway Pressure (CPAP) machines, designed to mitigate snoring and prevent sleep apnea. These CPAP devices precisely administer optimal air pressure to a mask, ensuring the maintenance of open upper airway passages.
Key categories within the sleep apnea devices market include airway clearance systems, adaptive servo-ventilation (ASV), positive airway pressure (PAP) devices, oral appliances, oxygen devices, sleep screening devices, actuation systems, polysomnography (PSG) devices, and respiratory polygraphs. Airway-clearing systems, a vital component, aid in the expulsion of thick mucus, facilitating coughing or huffing to clear the lungs. This technology is instrumental in addressing conditions such as obstructive sleep apnea syndrome, central sleep apnea syndrome, and complex sleep apnea syndrome. Targeting diverse age demographics, including pediatric, adult, and geriatric populations, these devices find application across various healthcare settings, such as hospitals, clinics, diagnostic centers, ambulatory care centers, specialty care centers, and home healthcare.
Tariffs have created cost pressures in the sleep apnea devices market by increasing the prices of imported electronic components, sensors, and medical-grade plastics used in CPAP machines, wearable actigraphy systems, and sleep screening devices. These impacts are most visible across PAP devices, oxygen devices, and sleep monitoring systems, particularly in Asia-Pacific and North American regions that rely heavily on cross-border manufacturing and supply chains. Higher import duties have led to elevated product prices and slower replacement cycles in hospitals, diagnostic centers, and home healthcare settings. However, tariffs are also encouraging manufacturers to localize production, strengthen regional supply networks, and invest in cost-efficient device designs, which may support long-term market stability and innovation.
The sleep apnea devices market research report is one of a series of new reports from The Business Research Company that provides sleep apnea devices market statistics, including sleep apnea devices industry global market size, regional shares, competitors with a sleep apnea devices market share, detailed sleep apnea devices market segments, market trends and opportunities, and any further data you may need to thrive in the sleep apnea devices industry. This sleep apnea devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The sleep apnea devices market size has grown strongly in recent years. It will grow from $8.37 billion in 2025 to $9.05 billion in 2026 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to rising awareness of sleep apnea, increasing prevalence of obesity, growth of sleep laboratories, improvement in CPAP technology, expansion of healthcare insurance coverage.
The sleep apnea devices market size is expected to see strong growth in the next few years. It will grow to $12.54 billion in 2030 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to growth of home healthcare, rising geriatric population, increasing adoption of portable sleep devices, higher healthcare spending, technological advancements in sleep monitoring. Major trends in the forecast period include home-based sleep apnea diagnosis, rising adoption of portable CPAP devices, growing preference for non-invasive oral appliances, increasing focus on patient comfort and compliance, expansion of sleep clinics and diagnostic centers.
The rising prevalence of obesity is expected to drive the growth of the sleep apnea devices market in the coming years. Obesity is a medical condition characterized by excessive body fat accumulation that poses health risks, commonly measured using the body mass index (BMI). Obesity is a significant risk factor for sleep apnea, and the global increase in obesity rates has contributed to the higher prevalence of this disorder. Consequently, there is growing demand for devices that can effectively manage sleep apnea. For instance, in May 2025, according to the Office for Health Improvement & Disparities, a UK-based government department, an estimated 64.5 percent of adults in England were overweight or living with obesity in 2023-2024, up from 64.0 percent in 2022-2023. Therefore, the rising obesity rates are boosting the sleep apnea devices market.
Major players in the sleep apnea devices market are embracing a strategic partnership approach to facilitate home-based sleep apnea detection. Strategic partnerships involve companies leveraging each other's strengths and resources for mutual benefit. For instance, in May 2023, Signifier Medical Technologies LLC, a US-based medical technology company, announced a partnership with Sunrise, a Hong Kong-based healthcare technology company. This collaboration integrates Sunrise's AI solutions with Signifier Medical's eXciteOSA daytime sleep apnea therapy technologies, enhancing patient care through more efficient diagnosis and treatments. The joint offering includes personalized home sleep testing and a patient management portal, empowering healthcare professionals to gather comprehensive information on patients' daily clinical experiences and optimize outcomes.
In July 2024, EnsoData, a U.S.-based software company, acquired sleep testing diagnostic technology from Resonea for an undisclosed sum. This acquisition is intended to significantly enhance EnsoData's capabilities in screening and diagnosing sleep apnea. The focus of this acquisition is to reduce costs and improve access to systematic screening for sleep apnea. Resonea is a company based in Arizona that specializes in sleep diagnostics.
Major companies operating in the sleep apnea devices market are ResMed Inc., Fisher And Paykel Healthcare Corporation Limited, Koninklijke Philips N.V., BMC Medical Co. Ltd., Lowenstein Medical Technology GmbH Co. KG, DeVilbiss Healthcare LLC, Drive DeVilbiss Healthcare, APEX Medical Corp., 3B Medical Inc., HOFFRICHTER GmbH, Circadiance LLC, Sleepnet Corporation, Oventus Medical Ltd., Inspire Medical Systems Inc., Provent Sleep Therapy LLC, Bleep LLC, Natus Medical Incorporated, Compumedics Limited, Braebon Medical Corporation, Cadwell Industries Inc., Itamar Medical Ltd., Somnoware Healthcare Systems Inc.
North America was the largest region in the sleep apnea devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global sleep apnea devices market during the forecast period. The regions covered in the sleep apnea devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the sleep apnea devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The sleep apnea devices market consists of sales of automatic positive airway pressure, biPAP machines, autoPAP machines, positional therapy devices, and implant systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Sleep Apnea Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses sleep apnea devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for sleep apnea devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The sleep apnea devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.